IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 1.932 SEK 1.68% Market Closed
Market Cap: 163.9m SEK

Intrinsic Value

The intrinsic value of one IRLAB A stock under the Base Case scenario is hidden SEK. Compared to the current market price of 1.932 SEK, IRLAB Therapeutics AB is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

IRLAB A Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
IRLAB Therapeutics AB

Intrinsic Value History
Dive into the past to invest in the future

IRLAB A looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if IRLAB A is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about IRLAB A?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IRLAB A valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for IRLAB Therapeutics AB.

Explain Valuation
Compare IRLAB A to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IRLAB A?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IRLAB Therapeutics AB

Current Assets 117.2m
Cash & Short-Term Investments 110.1m
Receivables 7m
Non-Current Assets 53.4m
PP&E 6.5m
Intangibles 46.9m
Other Non-Current Assets 1k
Current Liabilities 90m
Other Current Liabilities 90m
Non-Current Liabilities 26.3m
Long-Term Debt 26.3m
Efficiency

Free Cash Flow Analysis
IRLAB Therapeutics AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
IRLAB Therapeutics AB

Revenue
85.6m SEK
Cost of Revenue
-116.2m SEK
Gross Profit
-30.6m SEK
Operating Expenses
-43.9m SEK
Operating Income
-74.5m SEK
Other Expenses
-17.4m SEK
Net Income
-91.9m SEK
Fundamental Scores

IRLAB A Profitability Score
Profitability Due Diligence

IRLAB Therapeutics AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

IRLAB Therapeutics AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.

IRLAB A Solvency Score
Solvency Due Diligence

IRLAB Therapeutics AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

IRLAB Therapeutics AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IRLAB A Price Targets Summary
IRLAB Therapeutics AB

There are no price targets for IRLAB A.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

IRLAB Therapeutics AB
does not pay dividends
Shareholder Yield

Current shareholder yield for IRLAB A is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IRLAB A stock?

The intrinsic value of one IRLAB A stock under the Base Case scenario is hidden SEK.

Is IRLAB A stock undervalued or overvalued?

Compared to the current market price of 1.932 SEK, IRLAB Therapeutics AB is hidden .

Back to Top